Cargando…
Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide
Diallyl trisulfide (DATS) is an attractive anti-cancer phytochemical with in vitro and in vivo growth inhibitory effects against different solid tumors including breast cancer. We have shown previously that an immortalized mammary epithelial cell line (MCF-10A) is resistant to growth inhibition by D...
Autores principales: | Hahm, Eun-Ryeong, Mathan, Sivapar V., Singh, Rana P., Singh, Shivendra V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271405/ https://www.ncbi.nlm.nih.gov/pubmed/35864856 http://dx.doi.org/10.15430/JCP.2022.27.2.101 |
Ejemplares similares
-
Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis
por: Hahm, Eun-Ryeong, et al.
Publicado: (2021) -
Gene Expression Changes by Diallyl Trisulfide Administration in Chemically-induced Mammary Tumors in Rats
por: Hahm, Eun-Ryeong, et al.
Publicado: (2022) -
Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats
por: Kim, Su-Hyeong, et al.
Publicado: (2020) -
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
por: Malla, RamaRao, et al.
Publicado: (2022) -
Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment
por: Puccinelli, Michael T., et al.
Publicado: (2017)